MX9203254A - Compuestos complejos de metales para magneticos. - Google Patents

Compuestos complejos de metales para magneticos.

Info

Publication number
MX9203254A
MX9203254A MX9203254A MX9203254A MX9203254A MX 9203254 A MX9203254 A MX 9203254A MX 9203254 A MX9203254 A MX 9203254A MX 9203254 A MX9203254 A MX 9203254A MX 9203254 A MX9203254 A MX 9203254A
Authority
MX
Mexico
Prior art keywords
sub
sup
alkyl
cooz
hydroxy
Prior art date
Application number
MX9203254A
Other languages
English (en)
Spanish (es)
Inventor
Ernst Felder
Fulvio Uggeri
Luciano Fumagalli
Giorgio Vittadini
Original Assignee
Bracco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bracco Spa filed Critical Bracco Spa
Publication of MX9203254A publication Critical patent/MX9203254A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
MX9203254A 1986-01-30 1992-06-24 Compuestos complejos de metales para magneticos. MX9203254A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8619236A IT1213029B (it) 1986-01-30 1986-01-30 Chelati di ioni metallici paramagnetici.

Publications (1)

Publication Number Publication Date
MX9203254A true MX9203254A (es) 1992-07-01

Family

ID=11156003

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9203254A MX9203254A (es) 1986-01-30 1992-06-24 Compuestos complejos de metales para magneticos.

Country Status (14)

Country Link
US (3) US4916246A (cg-RX-API-DMAC7.html)
EP (1) EP0230893B1 (cg-RX-API-DMAC7.html)
JP (1) JPS62195388A (cg-RX-API-DMAC7.html)
AT (1) ATE53571T1 (cg-RX-API-DMAC7.html)
AU (1) AU591225B2 (cg-RX-API-DMAC7.html)
CA (1) CA1324150C (cg-RX-API-DMAC7.html)
DE (2) DE3763189D1 (cg-RX-API-DMAC7.html)
ES (1) ES2031832T3 (cg-RX-API-DMAC7.html)
GR (1) GR3000563T3 (cg-RX-API-DMAC7.html)
HK (1) HK95793A (cg-RX-API-DMAC7.html)
IT (1) IT1213029B (cg-RX-API-DMAC7.html)
LU (1) LU90285I2 (cg-RX-API-DMAC7.html)
MX (1) MX9203254A (cg-RX-API-DMAC7.html)
NL (1) NL980024I2 (cg-RX-API-DMAC7.html)

Families Citing this family (119)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3129906C3 (de) * 1981-07-24 1996-12-19 Schering Ag Paramagnetische Komplexsalze, deren Herstellung und Mittel zur Verwendung bei der NMR-Diagnostik
US5422096A (en) * 1985-05-08 1995-06-06 The General Hospital Corporation Hydroxy-aryl metal chelates for diagnostic NMR imaging
US5250285A (en) * 1985-05-08 1993-10-05 The General Hospital Corporation Hydroxy-aryl metal chelates for diagnostic NMR imaging
US4885363A (en) * 1987-04-24 1989-12-05 E. R. Squibb & Sons, Inc. 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
MX174467B (es) * 1986-01-23 1994-05-17 Squibb & Sons Inc 1,4,7-triscarboximetil-1,4,7,10-tetraazaciclodo decano substituido en 1 y compuestos analogos
AU605461B2 (en) * 1986-04-07 1991-01-17 Francois Dietlin New compositions usable in tomo-densitometry
US5338532A (en) * 1986-08-18 1994-08-16 The Dow Chemical Company Starburst conjugates
WO1995024221A1 (en) * 1986-08-18 1995-09-14 The Dow Chemical Company Bioactive and/or targeted dendrimer conjugates
US5560929A (en) * 1986-08-18 1996-10-01 The Dow Chemical Company Structured copolymers and their use as absorbents, gels and carriers of metal ions
US5527524A (en) * 1986-08-18 1996-06-18 The Dow Chemical Company Dense star polymer conjugates
US6312679B1 (en) 1986-08-18 2001-11-06 The Dow Chemical Company Dense star polymer conjugates as dyes
US5057302A (en) * 1987-02-13 1991-10-15 Abbott Laboratories Bifunctional chelating agents
DE3869251D1 (de) * 1987-07-16 1992-04-23 Nycomed As Aminopolycarbonsaeure und ihre derivate.
US5531978A (en) * 1987-07-16 1996-07-02 Nycomed Imaging As Aminopolycarboxylic acids and derivatives thereof
GB8801646D0 (en) * 1988-01-26 1988-02-24 Nycomed As Chemical compounds
US5696239A (en) * 1988-10-31 1997-12-09 The Dow Chemical Company Conjugates possessing ortho ligating functionality and complexes thereof
PH31170A (en) * 1988-10-31 1998-03-20 Dow Chemical Co Chelants possesing ortho ligating functionality and complexes thereof.
US5342604A (en) * 1988-10-31 1994-08-30 The Dow Chemical Company Complexes possessing ortho ligating functionality
US5314681A (en) * 1988-12-23 1994-05-24 Nycomed Innovation Ab Composition of positive and negative contrast agents for electron spin resonance enhanced magnetic resonance imaging
US5695739A (en) * 1989-06-30 1997-12-09 Schering Aktiengesellschaft Derivatized DTPA complexes, pharmaceutical agents containing these compounds, their use, and processes for their production
US6039931A (en) * 1989-06-30 2000-03-21 Schering Aktiengesellschaft Derivatized DTPA complexes, pharmaceutical agents containing these compounds, their use, and processes for their production
GB8916781D0 (en) * 1989-07-21 1989-09-06 Nycomed As Compositions
US5190744A (en) * 1990-03-09 1993-03-02 Salutar Methods for detecting blood perfusion variations by magnetic resonance imaging
US5494655A (en) * 1990-03-09 1996-02-27 The Regents Of The University Of California Methods for detecting blood perfusion variations by magnetic resonance imaging
WO1992017215A1 (en) 1990-03-28 1992-10-15 Nycomed Salutar, Inc. Contrast media
GB9006977D0 (en) 1990-03-28 1990-05-23 Nycomed As Compositions
US5370901A (en) * 1991-02-15 1994-12-06 Bracco International B.V. Compositions for increasing the image contrast in diagnostic investigations of the digestive tract of patients
JPH06507904A (ja) * 1991-05-23 1994-09-08 イマアーレクス・フアーマシユーチカル・コーポレーシヨン 磁気共鳴画像形成用の油脂可溶化合物
US6875864B2 (en) 1991-08-01 2005-04-05 Bracco International B.V. Aminocarboxylate ligands having substituted aromatic amide moieties
US5330742A (en) * 1991-08-05 1994-07-19 Mallinckrodt Medical, Inc. Methods and compositions for magnetic resonance imaging
AU2468392A (en) * 1991-08-29 1993-04-05 Cytel Corporation Novel immunosuppressants
US5385719A (en) * 1991-09-24 1995-01-31 Unger; Evan C. Copolymers and their use as contrast agents in magnetic resonance imaging and in other applications
US5324503A (en) * 1992-02-06 1994-06-28 Mallinckrodt Medical, Inc. Iodo-phenylated chelates for x-ray contrast
US5756688A (en) * 1992-10-14 1998-05-26 Sterling Winthrop Inc. MR imaging compositions and methods
WO1994008624A2 (en) * 1992-10-14 1994-04-28 Sterling Winthrop Inc. Therapeutic and diagnostic imaging compositions and methods
ES2105332T3 (es) * 1992-10-14 1997-10-16 Nycomed Imaging As Polimeros quelantes.
US5817292A (en) * 1992-10-14 1998-10-06 Nycomed Imaging As MR imaging compositions and methods
US5401492A (en) * 1992-12-17 1995-03-28 Sterling Winthrop, Inc. Water insoluble non-magnetic manganese particles as magnetic resonance contract enhancement agents
DE4302287A1 (de) * 1993-01-25 1994-07-28 Schering Ag Derivatisierte DTPA-Komplexe, diese Verbindungen enthaltende pharmazeutische Mittel, ihre Verwendung und Verfahren zu deren Herstellung
EP0703790B1 (en) * 1993-06-02 2000-08-16 BRACCO S.p.A. Iodinated paramagnetic chelates, and their use as contrast agents
US5284972A (en) * 1993-06-14 1994-02-08 Hampshire Chemical Corp. N-acyl-N,N',N'-ethylenediaminetriacetic acid derivatives and process of preparing same
WO1995015319A1 (en) * 1993-12-03 1995-06-08 Bracco S.P.A. Paramagnetic chelates for nuclear magnetic resonance diagnosis
US5730968A (en) * 1994-03-31 1998-03-24 Sterling Winthrop Inc. Segmented chelating polymers as imaging and therapeutic agents
WO1995027705A1 (en) * 1994-04-08 1995-10-19 Bracco International B.V. Aromatic amide compounds and metal chelates thereof
US5582814A (en) * 1994-04-15 1996-12-10 Metasyn, Inc. 1-(p-n-butylbenzyl) DTPA for magnetic resonance imaging
US5672335A (en) * 1994-11-30 1997-09-30 Schering Aktiengesellschaft Use of metal complexes as liver and gallbladder X-ray diagnostic agents
GB9501560D0 (en) 1995-01-26 1995-03-15 Nycomed Imaging As Contrast agents
CN1177357A (zh) * 1995-01-26 1998-03-25 耐克麦德英梅金公司 铋化合物
TW319763B (cg-RX-API-DMAC7.html) * 1995-02-01 1997-11-11 Epix Medical Inc
DE19507819A1 (de) * 1995-02-21 1996-08-22 Schering Ag DTPA-Monoamide der zentralen Carbonsäure und deren Metallkomplexe, diese Komplexe enthaltende pharmazeutische Mittel, deren Verwendung in der Diagnostik und Therapie sowie Verfahren zur Herstellung der Komplexe und Mittel
DE19507820A1 (de) * 1995-02-21 1996-08-22 Schering Ag Neuartig substituierte DTPA-Derivate, deren Metallkomplexe, diese Komplexe enthaltende pharmazeutische Mittel, deren Verwendung in der Diagnostik, sowie Verfahren zur Herstellung der Komplexe und Mittel
IT1290417B1 (it) * 1996-08-02 1998-12-03 Bracco Spa Composti chelanti derivati di acidi poliamminopolicarbossilici, loro chelati con ioni metallici paramagnetici, loro preparazione ed
US6403055B1 (en) 1996-08-02 2002-06-11 Dibra S.P.A. Diagnostic imaging contrast agent with improved in serum relaxivity
US6458337B1 (en) 1996-08-02 2002-10-01 Dibra S.P.A Diagnostic imaging contrast agent with improved in serum relaxivity
IT1283650B1 (it) * 1996-08-02 1998-04-23 Bracco Spa Chelati paramagnetici ad alta relassivita' in siero
DE19641197C2 (de) * 1996-09-24 1999-02-18 Schering Ag Ionenpaare und ihre Verwendung als Kontrastmittel
US5861140A (en) * 1996-11-20 1999-01-19 Hoechst Celanese Corp. Tripodal paramagnetic contrast agents for MR imaging
US5861138A (en) * 1996-11-20 1999-01-19 Hoechst Celanese Corp. Ligands for MRI contrast agent
US5824288A (en) * 1997-08-21 1998-10-20 Hoechst Celanese Corporation Thio-substituted pyridines as MRI ligand precursors
DE19744004C1 (de) * 1997-09-26 1999-07-22 Schering Ag Lipophile Metall-Komplexe für Nekrose und Infarkt-Imaging
US6495118B1 (en) * 1997-09-26 2002-12-17 Schering Aktiengesellschaft Lipophilic metal complexes for necrosis and infarction imaging
IT1297035B1 (it) 1997-12-30 1999-08-03 Bracco Spa Derivati dell'acido 1,4,7,10-tetraazaciclododecan-1,4-diacetico
IT1298613B1 (it) * 1998-03-10 2000-01-12 Bracco Spa Chelati complessi di manganese ad alta relassivita' in siero
IT1298614B1 (it) * 1998-03-10 2000-01-12 Bracco Spa Chelati complessi di manganese ad alta relassivita' in siero
ITMI981583A1 (it) * 1998-07-10 2000-01-10 Bracco Spa Processo per la preparazione dell'acido 4 -carbossi-5,8,11-tris (carbossimetil)-1-fenil-2-oxa-5,8,11-triazatridecan-13-oico
IT1304501B1 (it) * 1998-12-23 2001-03-19 Bracco Spa Uso di derivati di acidi biliari coniugati con complessi metallicicome "blood pool agents" per l'indagine diagnostica tramite risonanza
CA2441809C (en) 2001-03-27 2014-07-22 Biomira, Inc. Liposomal vaccines comprising dilipopeptides for modulating t1 and t2 immune responses
US7893223B2 (en) 2001-07-17 2011-02-22 Bracco Imaging S.P.A. Multidentate AZA ligands able to complex metal ions and the use thereof in diagnostics and therapy
US7157277B2 (en) * 2001-11-28 2007-01-02 Neose Technologies, Inc. Factor VIII remodeling and glycoconjugation of Factor VIII
US7173003B2 (en) 2001-10-10 2007-02-06 Neose Technologies, Inc. Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
US7214660B2 (en) 2001-10-10 2007-05-08 Neose Technologies, Inc. Erythropoietin: remodeling and glycoconjugation of erythropoietin
US20060069238A1 (en) * 2002-04-15 2006-03-30 Biomira, Inc. Synthetic glyco-lipo-peptides as vaccines
US8791070B2 (en) 2003-04-09 2014-07-29 Novo Nordisk A/S Glycopegylated factor IX
WO2006127896A2 (en) * 2005-05-25 2006-11-30 Neose Technologies, Inc. Glycopegylated factor ix
EP2055189A1 (en) 2003-04-09 2009-05-06 Neose Technologies, Inc. Glycopegylation methods and proteins/peptides produced by the methods
US9005625B2 (en) 2003-07-25 2015-04-14 Novo Nordisk A/S Antibody toxin conjugates
US20080305992A1 (en) 2003-11-24 2008-12-11 Neose Technologies, Inc. Glycopegylated erythropoietin
CA2547140A1 (en) * 2003-11-24 2005-06-09 Neose Technologies, Inc. Glycopegylated erythropoietin
US20060040856A1 (en) * 2003-12-03 2006-02-23 Neose Technologies, Inc. Glycopegylated factor IX
FR2867473B1 (fr) 2004-03-12 2006-06-23 Guerbet Sa Compose de porphyrines et utilisation a haut champ en irm
TW201204410A (en) 2004-04-01 2012-02-01 Oncothyreon Inc Mucinous glycoprotein (MUC-1) vaccine
JP4956426B2 (ja) * 2004-07-02 2012-06-20 ブラッコ・イメージング・ソシエタ・ペル・アチオニ 高緩和能造影剤
EP1771066A2 (en) 2004-07-13 2007-04-11 Neose Technologies, Inc. Branched peg remodeling and glycosylation of glucagon-like peptide-1 glp-1
KR100624670B1 (ko) 2004-10-28 2006-09-18 동국정밀화학(주) 가돌리늄-디에틸렌트리아민펜타아세트산 아미노알콜염 및이의 제조방법
ES2566670T3 (es) 2004-10-29 2016-04-14 Ratiopharm Gmbh Remodelación y glucopegilación del factor de crecimiento de fibroblastos (FGF)
MX2007008229A (es) 2005-01-10 2007-09-11 Neose Technologies Inc Factor estimulador de colonias de granulocitos glicopegilado.
AU2006210398A1 (en) * 2005-02-03 2006-08-10 Lantheus Medical Imaging, Inc. Steady state perfusion methods
EP2386571B1 (en) 2005-04-08 2016-06-01 ratiopharm GmbH Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
US8669236B2 (en) 2005-05-12 2014-03-11 The General Hospital Corporation Biotinylated compositions
BRPI0613510A2 (pt) 2005-06-28 2011-01-11 Biomira Inc processo de tratamento de pacientes com uma vacina de glicoproteìna mucinosa (muc-1)
BRPI0614839A2 (pt) * 2005-08-19 2009-05-19 Neose Technologies Inc fator vii e fator viia glicopeguilados
US20070105755A1 (en) 2005-10-26 2007-05-10 Neose Technologies, Inc. One pot desialylation and glycopegylation of therapeutic peptides
WO2007056191A2 (en) 2005-11-03 2007-05-18 Neose Technologies, Inc. Nucleotide sugar purification using membranes
US9187532B2 (en) 2006-07-21 2015-11-17 Novo Nordisk A/S Glycosylation of peptides via O-linked glycosylation sequences
WO2008057683A2 (en) 2006-10-03 2008-05-15 Novo Nordisk A/S Methods for the purification of polypeptide conjugates
EA017770B1 (ru) 2007-04-03 2013-03-29 Биодженерикс Аг Способы лечения с использованием гликопэгилированного g-csf
CN101778859B (zh) 2007-06-12 2014-03-26 诺和诺德公司 改良的用于生产核苷酸糖的方法
EP2626080A3 (en) 2008-02-27 2014-03-05 Novo Nordisk A/S Conjugated factor VIII molecules
EP2147684A1 (en) 2008-07-22 2010-01-27 Bracco Imaging S.p.A Diagnostic Agents Selective Against Metalloproteases
US20110077396A1 (en) * 2009-09-30 2011-03-31 General Electric Company Intermediates for hydroxylated contrast enhancement agents
US8378134B2 (en) 2009-09-30 2013-02-19 General Electric Company Hydroxylated contrast enhancement agents
EP2327395A1 (en) 2009-11-23 2011-06-01 Bracco Imaging S.p.A Process for the preparation of gadobenate dimeglumine complex in a solid form
EP2338874A1 (en) 2009-12-16 2011-06-29 Bracco Imaging S.p.A Process for the preparation of chelated compounds
KR20140023903A (ko) 2011-02-24 2014-02-27 온코타이레온, 인코포레이티드 항원보강제를 갖는 muc1 기초 당지질펩티드 백신
JP5688500B2 (ja) * 2011-03-09 2015-03-25 樫原 宏 強磁性有機磁性流体
WO2012136813A2 (en) 2011-04-07 2012-10-11 Universitetet I Oslo Agents for medical radar diagnosis
CN102408348A (zh) * 2011-07-26 2012-04-11 天津市海文普宁科技发展有限公司 一种钆贝葡胺的制备新方法
CN102603550B (zh) * 2012-02-16 2014-11-26 佛山普正医药科技有限公司 一种中间体bopta的制备方法
JP5786218B2 (ja) * 2012-03-26 2015-09-30 樫原 宏 新しい強磁性有機磁性流体の合成方法と利用方法
EP2890788A1 (en) 2012-08-31 2015-07-08 The General Hospital Corporation Biotin complexes for treatment and diagnosis of alzheimer's disease
RU2528414C1 (ru) 2013-01-25 2014-09-20 Закрытое Акционерное Общество "Фарм-Синтез" Циклический октапептид, радиофармацевтическое средство на его основе и способ применения радиофармацевтического средства для получения лекарственных (фармацевтических) средств для лечения новообразований, экспрессирующих соматостатиновые рецепторы
CN103664672B (zh) * 2013-10-21 2016-01-13 河北一品制药有限公司 一种工业化生产钆喷酸葡胺的制备方法
EP2977369A1 (en) 2014-07-24 2016-01-27 Bracco Imaging SPA Preparation of a solid form of gadobenate dimeglumine
HUE060536T2 (hu) 2015-12-10 2023-03-28 Bracco Imaging Spa Dimer kontrasztanyagok
US10781188B2 (en) 2015-12-10 2020-09-22 Bracco Imaging S.P.A. Contrast agents
EP3442949B1 (en) 2016-04-13 2022-06-08 Bracco Imaging S.p.A. Contrast agents
HUE056114T2 (hu) 2016-12-12 2022-01-28 Bracco Imaging Spa Dimer kontrasztanyagok
RU2706359C1 (ru) * 2019-04-11 2019-11-18 Федеральное государственное бюджетное образовательное учреждение высшего образования "Московская государственная академия ветеринарной медицины и биотехнологии - МВА имени К.И. Скрябина" (ФГБОУ ВО МГАВМиБ - МВА имени К.И. Скрябина) Способ получения триглицината кобальта дигидрата
BR112022009493A2 (pt) 2019-12-13 2022-08-16 Bracco Imaging Spa Fabricação de do3a protegido

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB723316A (en) * 1951-06-11 1955-02-09 Frederick Charles Bersworth Substituted alkylene polyamine acetic acid compounds
US3028407A (en) * 1958-04-18 1962-04-03 Geigy Chem Corp Substituted ethylenediamine compounds having aromatic rings
US3107260A (en) * 1960-11-29 1963-10-15 Geigy Chem Corp Triaminopropane hexa-acetic acid and metal chelates thereof
DE1223396B (de) * 1964-01-14 1966-08-25 Geigy Ag J R Verfahren zur Herstellung von Trinatriumsalzen der Zinkkomplexe der Diaethylentriamin-N, N. N', N", N"-pentaessigsaeure und der Triaethylentetramin-N, N, N', N", N''', N'''-hexaessigsaeure
US3679728A (en) * 1968-08-13 1972-07-25 Grace W R & Co Process for preparing methylenebisiminodiacetonitrile
US4069249A (en) * 1975-11-11 1978-01-17 W. R. Grace & Co. N,N-di-(hydroxybenzyl)-trimethylene diaminediacetic acids
US4352751A (en) * 1979-09-10 1982-10-05 Analytical Radiation Corporation Species-linked diamine triacetic acids and their chelates
US4432907A (en) * 1979-09-10 1984-02-21 Analytical Radiation Corporation Diamine acid fluorescent chelates
US4622420A (en) * 1980-03-18 1986-11-11 The Regents Of The University Of California Chelating agents and method
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
DE3129906C3 (de) * 1981-07-24 1996-12-19 Schering Ag Paramagnetische Komplexsalze, deren Herstellung und Mittel zur Verwendung bei der NMR-Diagnostik
SE8301395L (sv) * 1983-03-15 1984-09-16 Wallac Oy Kelatiserande foreningar med funktionella grupper vilka tillater kovalent koppling till bio-organiska molekyler
DE3316703A1 (de) * 1983-05-04 1984-11-08 Schering AG, 1000 Berlin und 4709 Bergkamen Orales kontrastmittel fuer die kernspintomographie und dessen herstellung
FR2550449B1 (fr) * 1983-08-12 1986-01-31 Commissariat Energie Atomique Agents de relaxation specifiques d'organes ou de pathologies, utilisables pour modifier les contrastes en imagerie medicale par resonance magnetique nucleaire
US4558145A (en) * 1983-10-21 1985-12-10 Ciba Geigy Corporation Preparation of Fe chelates
US4859451A (en) * 1984-10-04 1989-08-22 Salutar, Inc. Paramagnetic contrast agents for MR imaging
US4687659A (en) * 1984-11-13 1987-08-18 Salutar, Inc. Diamide-DTPA-paramagnetic contrast agents for MR imaging
US4687658A (en) * 1984-10-04 1987-08-18 Salutar, Inc. Metal chelates of diethylenetriaminepentaacetic acid partial esters for NMR imaging
US4828014A (en) * 1985-12-13 1989-05-09 Inland Steel Company Continuous casting tundish and assembly
US4822594A (en) * 1987-01-27 1989-04-18 Gibby Wendell A Contrast enhancing agents for magnetic resonance images
DE3712329A1 (de) * 1987-04-11 1988-10-20 Basf Ag Verfahren zur herstellung von serin-n,n-diessigsaeure und derivaten, ihre verwendung insbesondere als komplexbildner und diese enthaltende wasch- und reinigungsmittel
DE3739610A1 (de) * 1987-11-23 1989-06-01 Basf Ag Nitrilo-di-aepfel-mono-essigsaeuren, verfahren zu ihrer herstellung und ihre verwendung
DE3914980A1 (de) * 1989-05-06 1990-12-06 Basf Ag 2-methyl- und 2-hydroxymethyl-serin-n,n-diessigsaeure und ihre derivate

Also Published As

Publication number Publication date
DE19875036I2 (de) 2001-06-13
ES2031832T3 (es) 1993-01-01
AU6753987A (en) 1987-08-06
AU591225B2 (en) 1989-11-30
DE19875036I1 (de) 2000-01-20
US5182370A (en) 1993-01-26
GR3000563T3 (en) 1991-07-31
NL980024I1 (nl) 1998-11-02
US4916246A (en) 1990-04-10
US4980502A (en) 1990-12-25
IT8619236A0 (it) 1986-01-30
HK95793A (en) 1993-09-24
JPS62195388A (ja) 1987-08-28
EP0230893B1 (en) 1990-06-13
JPH0364504B2 (cg-RX-API-DMAC7.html) 1991-10-07
EP0230893A2 (en) 1987-08-05
IT1213029B (it) 1989-12-07
ATE53571T1 (de) 1990-06-15
LU90285I2 (fr) 1999-02-25
EP0230893A3 (en) 1988-06-01
DE3763189D1 (de) 1990-07-19
CA1324150C (en) 1993-11-09
NL980024I2 (nl) 1999-03-01

Similar Documents

Publication Publication Date Title
MX9203254A (es) Compuestos complejos de metales para magneticos.
IE45225L (en) Dicarboxylic acid bis-(3,5-dicarbamoyl-2,4,6-triiodoanilide)¹compounds
EP0299795A3 (en) Aminopolycarboxylic acids and derivatives thereof
WO1997043293A1 (en) Contrast agents
GB9711093D0 (en) Novel orally active iron (III) chelators
ATE28187T1 (de) Polyprenylcarbonsaeureamide und verfahren zu ihrer herstellung.
GB1499026A (en) Adriamycin esters
CA1175059A (en) Sweetening preparations, new 2,4,6-trihalogenated benzamides substituted in the 3-position and salts thereof suitable as active ingredients therefor and the manufacture of suchcompounds
ES469613A1 (es) Procedimiento para la obtencion de compuetos de fenilaceta- mida
CA2098712A1 (en) Chelating agents
ES8707919A1 (es) Procedimiento para la obtencion de cosmeticos supresores delsebo a base de acidos alcoxi- o alquil-benciloxi- benzoicos o sus sales
IE44180L (en) Azaprostaglandins.
ES444957A1 (es) Procedimiento para preparar derivados de acido glicirretini-co.
ES445944A1 (es) Procedimiento de preparacion de derivados de 8-amino-teofi- lina.
ES428213A1 (es) Procedimiento para la obtencion de esteres dialquilaminoal-quilicos de penicilina.
IE46118L (en) Triazolidine diones
GB988512A (en) Improvements in and relating to esters of sulphonium salts
ES8502961A1 (es) Procedimiento para la fabricacion de los derivados del acido bicilo (3.2.1) octan carboxilico-3
SU1596399A1 (ru) Ферритовый материал
ES8506578A1 (es) Un procedimiento para la produccion de compuestos poliprenilicos
ES453997A1 (es) Procedimiento para la preparacion de acetatos de eteraminas secundarias.
Felder et al. 4980502 Paramagnetic chelates
Breneman et al. 4980641 Method and apparatus of reducing magnetic hysteresis in MRI systems
CH613933A5 (en) Process for the preparation of [1-oxo-2-aryl- or -thienyl-2-subst.-5-indanyloxy- (or -thio)]alkanecarboxylic acids or their alkyl esters
IE44093L (en) Salts of p-chlorophenoxy acetic acid dimethylaminoethyl¹ester